iMed.ULisboa - Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal; Centro de Química e Bioquímica (CQB) e Centro de Química Estrutural (CQE), Faculdade de Ciências, Universidade de Lisboa, Ed. C8, Campo Grande, 1749-016 Lisboa, Portugal; Sir Martin Evans Building, School of Biosciences, Cardiff University, Museum Avenue, Cardiff, UK.
Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel; Heyrovský Institute of Physical Chemistry of the Czech Academy of Sciences, Dolejškova 3, 182 23 Prague, Czech Republic.
Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Aug;1866(8):158944. doi: 10.1016/j.bbalip.2021.158944. Epub 2021 May 1.
Niemann-Pick disease type C (NPC) is a complex and rare pathology, which is mainly associated to mutations in the NPC1 gene. This disease is phenotypically characterized by the abnormal accumulation of multiple lipid species in the acidic compartments of the cell. Due to the complexity of stored material, a clear molecular mechanism explaining NPC pathophysiology is still not established. Abnormal sphingosine accumulation was suggested as the primary factor involved in the development of NPC, followed by the accumulation of other lipid species. To provide additional mechanistic insight into the role of sphingosine in NPC development, fluorescence spectroscopy and microscopy were used to study the biophysical properties of biological membranes using different cellular models of NPC. Addition of sphingosine to healthy CHO-K1 cells, in conditions where other lipid species are not yet accumulated, caused a rapid decrease in plasma membrane and lysosome membrane fluidity, suggesting a direct effect of sphingosine rather than a downstream event. Changes in membrane fluidity caused by addition of sphingosine were partially sustained upon impaired trafficking and metabolization of cholesterol in these cells, and could recapitulate the decrease in membrane fluidity observed in NPC1 null Chinese Hamster Ovary (CHO) cells (CHO-M12) and in cells with pharmacologically induced NPC phenotype (treated with U18666A). In summary, these results show for the first time that the fluidity of the membranes is altered in models of NPC and that these changes are in part caused by sphingosine, supporting the role of this lipid in the pathophysiology of NPC.
尼曼-匹克病 C 型(NPC)是一种复杂且罕见的病理学疾病,主要与 NPC1 基因突变有关。这种疾病在表型上的特征是细胞内酸性隔室中多种脂质物质的异常积累。由于储存物质的复杂性,目前尚未建立明确的分子机制来解释 NPC 的病理生理学。异常的神经酰胺积累被认为是 NPC 发病机制的主要因素,其次是其他脂质物质的积累。为了提供更多关于神经酰胺在 NPC 发展中的作用的机制见解,使用荧光光谱学和显微镜技术,使用不同的 NPC 细胞模型研究了生物膜的生物物理特性。在尚未积累其他脂质物质的情况下,向健康的 CHO-K1 细胞中添加神经酰胺会导致质膜和溶酶体膜流动性迅速下降,这表明神经酰胺具有直接作用,而不是下游事件。在这些细胞中胆固醇的转运和代谢受损的情况下,添加神经酰胺引起的膜流动性变化部分得到维持,并且可以再现 NPC1 缺失的中国仓鼠卵巢(CHO)细胞(CHO-M12)和用药理学诱导 NPC 表型的细胞(用 U18666A 处理)中观察到的膜流动性降低。总之,这些结果首次表明,在 NPC 模型中,膜的流动性发生改变,并且这些变化部分是由神经酰胺引起的,这支持了这种脂质在 NPC 病理生理学中的作用。